Carmustine and Pelvic venous thrombosis - a phase IV clinical study of FDA data

Summary:

Pelvic venous thrombosis is reported as a side effect among people who take Carmustine (carmustine), especially for people who are 50-59 old, have been taking the drug for < 1 month also take Cytarabine, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Pelvic venous thrombosis when taking Carmustine. It is created by eHealthMe based on reports of 4,562 people who have side effects when taking Carmustine from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Pelvic venous thrombosis?

Pelvic venous thrombosis (blood clot occurring inside a blood vessel and thromboses (dvts) that form in the deep veins of the legs or in the pelvic veins) is found to be associated with 191 drugs and 383 conditions by eHealthMe. Check the latest studies of Pelvic venous thrombosis.

On Jul, 28, 2026

4,562 people reported to have side effects when taking Carmustine.
Among them, 12 people (0.26%) have Pelvic venous thrombosis.

Could Carmustine cause Pelvic venous thrombosis?

Among these 12 people:

How long have people been on Carmustine when they have Pelvic venous thrombosis? *

What is the age of people who have Pelvic venous thrombosis when taking Carmustine? *

What are other drugs people take besides Carmustine? *

What are other side effects people have besides Pelvic venous thrombosis? *

Scar: 10 people, 83.33%
Disease Progression: 10 people, 83.33%
Bile Duct Obstruction (blockage in the tubes that carry bile from the liver to the gallbladder): 10 people, 83.33%
Urinary Retention (the inability to completely or partially empty the bladder): 10 people, 83.33%
Blood Bilirubin Increased: 10 people, 83.33%
Hepatic Cyst: 10 people, 83.33%
Glomerular Filtration Rate Decreased: 10 people, 83.33%
Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 10 people, 83.33%
Fever: 2 people, 16.67%
Joint Pain: 1 person, 8.33%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 11 people, 91.67%
Leukaemic Lymphoma (a rare cancer of the immune systems own t-cells): 1 person, 8.33%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and have Pelvic venous thrombosis?

- Check whether Pelvic venous thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carmustine:

Carmustine (4,562 reports)

Browse all side effects of Carmustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pelvic venous thrombosis:

Pelvic venous thrombosis (192 drugs)

Browse all the conditions that are associated with Pelvic venous thrombosis:

Pelvic venous thrombosis (383 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Carmustine) and Carmustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.